BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36278398)

  • 1. SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.
    Wu X; Liu H; Brooks A; Xu S; Luo J; Steiner R; Mickelsen DM; Moravec CS; Jeffrey AD; Small EM; Jin ZG
    Circ Res; 2022 Nov; 131(11):926-943. PubMed ID: 36278398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of heart failure with preserved ejection fraction in type 2 diabetic mice is ameliorated by preserving vascular function.
    Otto M; Brabenec L; Müller M; Kintrup S; Hellenthal KEM; Holtmeier R; Steinbuch SC; Karsten OS; Pryvalov H; Rossaint J; Gross ER; Wagner NM
    Life Sci; 2021 Nov; 284():119925. PubMed ID: 34480933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT6 transcriptionally regulates fatty acid transport by suppressing PPARγ.
    Khan D; Ara T; Ravi V; Rajagopal R; Tandon H; Parvathy J; Gonzalez EA; Asirvatham-Jeyaraj N; Krishna S; Mishra S; Raghu S; Bhati AS; Tamta AK; Dasgupta S; Kolthur-Seetharam U; Etchegaray JP; Mostoslavsky R; Rao PSM; Srinivasan N; Sundaresan NR
    Cell Rep; 2021 Jun; 35(9):109190. PubMed ID: 34077730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAX1BP1 downregulation by STAT3 in cardiac fibroblasts contributes to diabetes-induced heart failure with preserved ejection fraction.
    Zuo GF; Wang LG; Huang L; Ren YF; Ge Z; Hu ZY; Zhang JJ; Chen SL
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166979. PubMed ID: 38065272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice.
    Qin K; Zhang N; Zhang Z; Nipper M; Zhu Z; Leighton J; Xu K; Musi N; Wang P
    Diabetologia; 2018 Apr; 61(4):906-918. PubMed ID: 29322219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction.
    Wang YC; Koay YC; Pan C; Zhou Z; Tang W; Wilcox J; Li XS; Zagouras A; Marques F; Allayee H; Rey FE; Kaye DM; O'Sullivan JF; Hazen SL; Cao Y; Lusis AJ
    Circ Res; 2024 Feb; 134(4):371-389. PubMed ID: 38264909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction.
    Zhang N; Ma Q; You Y; Xia X; Xie C; Huang Y; Wang Z; Ye F; Yu Z; Xie X
    Int J Biol Sci; 2022; 18(3):1271-1287. PubMed ID: 35173552
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
    Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
    J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial Senescence Contributes to Heart Failure With Preserved Ejection Fraction in an Aging Mouse Model.
    Gevaert AB; Shakeri H; Leloup AJ; Van Hove CE; De Meyer GRY; Vrints CJ; Lemmens K; Van Craenenbroeck EM
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.
    Lindman BR; Dávila-Román VG; Mann DL; McNulty S; Semigran MJ; Lewis GD; de las Fuentes L; Joseph SM; Vader J; Hernandez AF; Redfield MM
    J Am Coll Cardiol; 2014 Aug; 64(6):541-9. PubMed ID: 25104521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a "2-Hit" Murine Model.
    LaPenna KB; Li Z; Doiron JE; Sharp TE; Xia H; Moles K; Koul K; Wang JS; Polhemus DJ; Goodchild TT; Patel RB; Shah SJ; Lefer DJ
    J Am Heart Assoc; 2023 Feb; 12(4):e028480. PubMed ID: 36752224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological mechanism of heart failure with preserved ejection fraction in rats based on iTRAQ technology.
    Xu H; Gao K; Liu C; Li T; Ding Y; Ma J
    PeerJ; 2023; 11():e15280. PubMed ID: 37159835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT6 mediated histone H3K9ac deacetylation involves myocardial remodelling through regulating myocardial energy metabolism in TAC mice.
    Wu S; Zhang J; Peng C; Ma Y; Tian X
    J Cell Mol Med; 2023 Nov; 27(22):3451-3464. PubMed ID: 37603612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy.
    Costantino S; Mengozzi A; Velagapudi S; Mohammed SA; Gorica E; Akhmedov A; Mongelli A; Pugliese NR; Masi S; Virdis A; Hülsmeier A; Matter CM; Hornemann T; Melina G; Ruschitzka F; Luscher TF; Paneni F
    Cardiovasc Diabetol; 2023 Nov; 22(1):312. PubMed ID: 37957697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An herbal preparation ameliorates heart failure with preserved ejection fraction by alleviating microvascular endothelial inflammation and activating NO-cGMP-PKG pathway.
    Huang Y; Zhang K; Liu M; Su J; Qin X; Wang X; Zhang J; Li S; Fan G
    Phytomedicine; 2021 Oct; 91():153633. PubMed ID: 34320423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.
    Curl CL; Danes VR; Bell JR; Raaijmakers AJA; Ip WTK; Chandramouli C; Harding TW; Porrello ER; Erickson JR; Charchar FJ; Kompa AR; Edgley AJ; Crossman DJ; Soeller C; Mellor KM; Kalman JM; Harrap SB; Delbridge LMD
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
    Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
    JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis.
    Tan W; Wang Y; Cheng S; Liu Z; Xie M; Song L; Qiu Q; Wang X; Li Z; Liu T; Guo F; Wang J; Zhou X
    J Adv Res; 2024 Feb; ():. PubMed ID: 38382593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.